#2903
Bone Metastases (BM) in Neuroendocrine Tumors (NET): Imaging Characteristics and Clinical Implications. A Single-Institution Experience
Introduction:
The incidence of BM in NET is underestimated and there is no consensus on clinical features, diagnostic techniques, and treatment options.
Conference:
17th Annual ENETSConcerence (2020)
Presenting Author:
Smiroldo V
Authors:
Smiroldo V,
Lania A,
Pedicini V,
Pepe G,
Zerbi A,
Keywords:
bone metastases,
skeletal related event,
survival,
bisphosphonates,
68Ga-PET,
18FDG-PET,
CT scan,
#1826
An Intrapatient Comparison of 18FDG And 68Ga-DOTA-TATE PET/CT Imaging in Patients with Gastrointestinal Neuroendocrine Neoplasm
Introduction:
18FDG-PET/CT was the most widely used functional imaging for cancer, while 68Ga-DOTA-TATE PET/CT could evaluate the SSTR expression of NEN.
Conference:
14th Annual ENETSConcerence (2017)
Presenting Author:
Yu J
Authors:
Yu J,
lI J,
Zhang P,
Lu M,
Yang Z,
Keywords:
18FDG,
gastrointestinal,
neuroendocrine,
neoplasm,
standard,
uptake,
value,
#1317
Value of Octreoscan and 18FDG-PET for Clinical Prognosis of Patients with Neuroendocrine Neoplasms
Introduction:
Despite the existence of biological markers of aggressiveness, the clinical course of gastro-entero-pancreatic (GEP) neuroendocrine neoplasms (NEN) remains difficult to predict. Discrepancies between imaging data generated with 111In-pentetreotide scintigraphy (SRS) and 18 F-FDG-PET could reflect the degree of cellular de-differentiation.
Conference:
13th Annual ENETSConcerence (2016)
Presenting Author:
Gouffon M
Authors:
Gouffon M,
Prior J,
Ratib O,
Krause T,
Pralong F,
Keywords:
111In-pentetreotide scintigraphy,
18F-FDG-PET,
prognosis,
clinical course,
